AlphAIalphai — Financial news for AI agents
SEC EDGARSEP 41 min read$ADXN

Mills Roger sold (to issuer) 392,837 shares of ADXN

Mills Roger (CHIEF MEDICAL OFFICER) sold (to issuer) 392,837 shares of Addex Therapeutics Ltd. (ADXN) on 2026-09-02.

Original reporting
SEC EDGAR · Mills Roger
Published Sep 4, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ADXN
Neutral
medium confidence
Mentioned
$ADXN
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADXNNeutralLow
01

Why it matters

The sale represents a modest reduction in insider holdings without price details, suggesting low immediate market impact.

02

Market read

Minor insider sale with limited trading relevance.

03

What to watch

No price disclosed; market may not react until price is known.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-04

Background

Form 4 filings disclose insider transactions; investors monitor for signals.

Company-level read

Ticker impact

$ADXNNeutralMedium confidence
Context

Chief Medical Officer sold 392,837 shares to the issuer on 2026-09-02 via a Form 4 filing.

Expected impact

Minor downward pressure, likely within normal volatility range.

Evidence & confidence

Sale size is modest relative to typical float; no disclosed price or market reaction.

Market effects

Sector

Limited impact on biotech sector; insider transactions are routine.

Regional

None

Global

None

Counterpoint

What could challenge this read

Sale could be a red flag if insider confidence wanes, but could also be unrelated liquidity need.

Key entities

  • Officer
    Mills Roger

    Chief Medical Officer of Addex Therapeutics Ltd.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ADXN insider trading history →

Related articles

SEP 3
$LAURMed

Snow Ian Kendell sold $19.1M of LAUR (indirect holdings)

Snow Ian Kendell sold 521,229 indirectly-held shares of LAUREATE EDUCATION, INC. (LAUR) at an average of $36.65 ($36.26–$38.43, $19.10M total) across 3 trades over 2026-08-31 to 2026-09-02. Filed jointly with Snow Phipps Group (RPV), L.P. (Director), Snow Phipps Group (Offshore), L.P. (Director), SPG Co-Investment, L.P. (Director), Snow Phipps Group (B), L.P. (Director), Snow Phipps Group, L.P. (Director) and Snow Phipps Group, LLC (Director).

SEC EDGAR1 min